Cargando…
Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
The prevalence of Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is expected to more than double by 2050. Studies on the pathophysiology of AD have been changing our understanding of this disorder and setting a new scenario for drug development and other therapies. Concepts like...
Autores principales: | Pais, Marcos, Martinez, Luana, Ribeiro, Octávio, Loureiro, Júlia, Fernandez, Romel, Valiengo, Leandro, Canineu, Paulo, Stella, Florindo, Talib, Leda, Radanovic, Marcia, Forlenza, Orestes V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430379/ https://www.ncbi.nlm.nih.gov/pubmed/31994640 http://dx.doi.org/10.1590/1516-4446-2019-0735 |
Ejemplares similares
-
Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis
por: Costa, Alana, et al.
Publicado: (2022) -
Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment
por: Radanovic, Márcia, et al.
Publicado: (2017) -
Mood disorders in the elderly: prevalence, functional impact, and management challenges
por: Valiengo, Leandro da Costa Lane, et al.
Publicado: (2016) -
Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort
por: Radanovic, Márcia, et al.
Publicado: (2019) -
Electroconvulsive therapy for treating patients with agitation and related behavioral disorders due to dementia: a systematic review
por: Stella, Florindo, et al.
Publicado: (2023)